The actin-ADP-ribosylating Clostridium botulinum C2 toxin

Anaerobe

Volumn 10, Issue 2, 2004, Pages 101-105

  Aktories, Klaus ^a   Barth, Holger ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ADENOSINE DIPHOSPHATE RIBOSE; BOTULINUM TOXIN; F ACTIN; G ACTIN; GELDANAMYCIN; NEUROTOXIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NICOTINAMIDE ADENINE DINUCLEOTIDE NUCLEOSIDASE; RUBIDIUM;

ACTIN POLYMERIZATION; AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; BACTERIAL CHROMOSOME; BACTERIAL STRAIN; BETA SHEET; CATALYSIS; CELL MIGRATION; CELL STRUCTURE; CLOSTRIDIUM BOTULINUM; COVALENT BOND; CRYSTAL STRUCTURE; CYTOSKELETON; CYTOSOL; ENDOCYTOSIS; ENZYME ACTIVITY; GENE FUNCTION; GENE MUTATION; GENE SEQUENCE; MOLECULAR MECHANICS; NEUROTRANSMITTER RELEASE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN LOCALIZATION; REVIEW; STRUCTURE ANALYSIS; TOXIN SYNTHESIS; TRANSCRIPTION INITIATION;

CLOSTRIDIUM; CLOSTRIDIUM BOTULINUM;

EID: 1942454223     PISSN: 10759964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.anaerobe.2003.10.003     Document Type: Short Survey

References (56)

1. Stiles B.G., Wilkens T.D. Purification and characterization of Clostridium perfringens iota toxin. dependence on two nonlinked proteins for biological activity Infect Immun. 54:1986;683-688.
2. Popoff M.R., Milward F.W., Bancillon B., Boquet P. Purification of the Clostridium spiroforme binary toxin and activity of the toxin on HEp2 cells. Infect Immun. 57:1989;2462-2469.
3. Perelle S., Gibert M., bourlioux P., Corthier G., Popoff M.R. Production of a complete binary toxin (actin-specific ADP-ribosyltransferase) by Clostridium difficile CD196. Infect Immun. 65:1997;1402-1407.
4. Gülke I., Pfeifer G., Liese J., Fritz M., Hofmann F., Aktories K., Barth H. Characterization of the enzymatic component of the ADP- ribosyltransferase toxin CDTa from Clostridium difficile. Infect Immun. 69:2001;6004-6011.
5. Han S., Craig J.A., Putnam C.D., Carozzi N.B., Tainer J.A. Evolution and mechanism from structures of an ADP-ribosylating toxin and NAD complex. Nat Struct Biol. 6:1999;932-936.
6. Ohishi I., Iwasaki M., Sakaguchi G. Purification and characterization of two components of botulinum C2 toxin. Infect Immun. 30:1980;668-673.
7. Ohishi I. Lethal and vascular permeability activities of botulinum C2 toxin induced by separate injections of the two toxin components. Infect Immun. 40:1983;336-339.
8. Simpson L.L. The binary toxin produced by Clostridium botulinum enters cells by receptor-mediated endocytosis to exert its pharmacologic effects. J Pharmacol Exp Ther. 251:1989;1223-1228.
9. Simpson L.L. Molecular basis for the pharmacological actions of Clostridium botulinum type C2 toxin. J Pharmacol Exp Ther. 230:1984;665-669.
10. Aktories K., Bärmann M., Ohishi I., Tsuyama S., Jakobs K.H., Habermann E. Botulinum C2 toxin ADP-ribosylates actin. Nature. 322:1986;390-392.
11. Aktories K., Ankenbauer T., Schering B., Jakobs K.H. ADP-ribosylation of platelet actin by botulinum C2 toxin. Eur J Biochem. 161:1986;155-162.
12. Wegner A., Aktories K. ADP-ribosylated actin caps the barbed ends of actin filaments. J Biol Chem. 263:1988;13739-13742.
13. Weigt C., Just I., Wegner A., Aktories K. Nonmuscle actin ADP-ribosylated by botulinum C2 toxin caps actin filaments. FEBS Lett. 246:1989;181-184.
14. Wille M., Just I., Wegner A., Aktories K. ADP-ribosylation of the gelsolin-actin complex by clostridial toxins. J Biol Chem. 267:1992;50-55.
15. Reuner K.H., Presek P., Boschek C.B., Aktories K. Botulinum C2 toxin ADP-ribosylates actin and disorganizes the microfilament network in intact cells. Eur J Cell Biol. 43:1987;134-140.
16. Schering B., Bärmann M., Chhatwal G.S., Geipel U., Aktories K. ADP-ribosylation of skeletal muscle and non-muscle actin by Clostridium perfringens iota toxin. Eur J Biochem. 171:1988;225-229.
17. Mauss S., Chaponnier C., Just I., Aktories K., Gabbiani G. ADP-ribosylation of actin isoforms by Clostridium botulinum C2 toxin and Clostridium perfringens iota toxin. Eur J Biochem. 194:1990;237-241.
18. Sotiropoulos A., Gineitis D., Copeland J., Treisman R. Signal-regulated activation of serum response factor is mediated by changes in actin dynamics. Cell. 98:1999;159-169.
19. Ohishi I. Response of mouse intestinal loop to botulinum C2 toxin. enterotoxic activity induced by cooperation of nonlinked protein components Infect Immun. 40:1983;691-695.
20. Ohishi I., Odagiri Y. Histopathological effect of Botulinum C2 toxin on mouse intestines. Infect Immun. 43:1984;54-58.
21. Considine R.V., Simpson L.L. Cellular and molecular actions of binary toxins possessing ADP-ribosyltransferase activity. Toxicon. 29:1991;913-936.
22. Rubin E.J., Gill D.M., Boquet P., Popoff M.R. Functional modification of a 21-Kilodalton G protein when ADP-ribosylated by exoenzyme C3 of Clostridium botulinum. Mol Cell Biol. 8:1988;418-426.
23. Fujii N., Kubota T., Shirakawa S., Kimura K., Ohishi I., Moriishi K., Isogai E., Isogai H. Characterization of component-I gene of botulinum C2 toxin and PCR detection of its gene in clostridial species. Biochem Biophys Res Commun. 220:1996;353-359.
24. Barth H., Hofmann F., Olenik C., Just I., Aktories K. The N-terminal part of the enzyme component (C2I) of the binary Clostridium botulinum C2 toxin interacts with the binding component C2II and functions as a carrier system for a Rho ADP-ribosylating C3-like fusion toxin. Infect Immun. 66:1998;1364-1369.
25. Barth H., Roebling R., Fritz M., Aktories K. The binary Clostridium botulinum C2 toxin as a protein delivery system. J Biol Chem. 277:2002;5074-5081.
26. Blöcker D., Barth H., Maier E., Benz R., Barbieri J.T., Aktories K. The C-terminus of component C2II of Clostridium botulinum C2 toxin is essential for receptor binding. Infect Immun. 68:2000;4566-4573.
27. Choe S., Bennett M.J., Fujii G., Curmi P.M.G., Kantardjieff K.A., Collier R.J., Eisenberg D. The crystal structure of diphtheria toxin. Nature. 357:1992;216-222.
28. Li M., Dyda F., Benhar I., Pastan I., Davies D.R. Crystal structure of the catalytic domain of Pseudomonas exotoxin A complexed with a nicotinamide adenine dinucleotide analog. implications for the activation process and for ADP ribosylation Proc Natl Acad Sci USA. 93:1996;6902-6906.
29. Sixma T.K., Pronk S.E., Kalk K.H., Wartna E.S., van Zanten B.A.M., Witholt B., Hol W.G.J. Crystal structure of a cholera toxin-related heat-labile enterotoxin from E. coli. Nature. 351:1991;371-377.
30. Stein P.E., Boodhoo A., Armstrong G.D., Cockle S.A., Klein M.H., Read R.J. The crystal structure of pertussis toxin. Structure. 2:1994;45-57.
31. Carroll S.F., Collier R.J. NAD binding site of diphtheria toxin. identification of a residue within the nicotinamide subsite by photochemical modification with NAD Proc Natl Acad Sci USA. 81:1984;3307-3311.
32. Jung M., Just I., van Damme J., Vandekerckhove J., Aktories K. NAD-binding site of the C3-like ADP-ribosyltransferase from Clostridium limosum. J Biol Chem. 268:1993;23215-23218.
33. Takada T., Iida K., Moss J. Conservation of a common motif in enzymes catalyzing ADP-ribose transfer. J Biol Chem. 270:1995;541-544.
34. Barth H., Preiss J.C., Hofmann F., Aktories K. Characterization of the catalytic site of the ADP-ribosyltransferase Clostridium botulinum C2 toxin by site-directed mutagenesis. J Biol Chem. 273:1998;29506-29511.
35. Tsuge H., Nagahama M., Nishimura H., Hisatsune J., Sakaguchi Y., Itogawa Y., Katunuma N., Sakurai J. Crystal structure and site-directed mutagenesis of enzymatic components from Clostridium perfringens iota-toxin. J Mol Biol. 325:2003;471-483.
36. Marvaud J.C., Stiles B.G., Chenal A., Gillet D., Gibert M., Smith L.A., Popoff M.R. Clostridium perfringens iota toxin. Mapping of the Ia domain involved in docking with Ib and cellular internalization. J Biol Chem. 277:2002;43659-43666.
37. Ohishi I. Activation of botulinum C2 toxin by trypsin. Infect Immun. 55:1987;1461-1465.
38. Kimura K., Kubota T., Ohishi I., Isogai E., Isogai H., Fujii N. The gene for component-II of botulinum C2 toxin. Vet Microbiol. 62:1998;27-34.
39. Leppla S.H. Anthrax toxins. Moss J., Iglewski B., Vaughan M., Tu A.T. Handbook of natural toxins, vol 8, Bacterial toxins and virulence factors in disease. 1995;543-572 Marcel Dekker, New York.
40. Beauregard K.E., Wimer-Mackin S., Collier R.J., Lencer W.I. Anthrax toxin entry into polarized epithelial cells. Infect Immun. 67:1999;3026-3030.
41. Miller C.J., Elliott J.L., Collier R.J. Anthrax protective antigen. prepore-to-pore conversion Biochemistry. 38:1999;10432-10441.
42. Petosa C., Collier R.J., Klimpel K.R., Leppla S.H., Liddingtom R.C. Crystal structure of the anthrax toxin protective antigen. Nature. 385:1997;833-838.
43. Wesche J., Elliott J.L., Falnes P.O., Olsnes S., Collier R.J. Characterization of membrane translocation by anthrax protective antigen. Biochemistry. 37:1998;15737-15746.
44. Barth H., Blöcker D., Behlke J., Bergsma-Schutter W., Brisson A., Benz R., Aktories K. Cellular uptake of Clostridium botulinum C2 toxin requires oligomerization and acidification. J Biol Chem. 275:2000;18704-18711.
45. Schmid A., Benz R., Just I., Aktories K. Interaction of Clostridium botulinum C2 toxin with lipid bilayer membranes. formation of cation-selective channels and inhibition of channel function by chloroquine and peptides J Biol Chem. 269(24):1994;16706-16711.
46. Knapp O., Benz R., Gibert M., Marvaud J.C., Popoff M.R. Interaction of the binding component of Clostridium perfringens iota-toxin with lipid bilayer membranes. demonstration of channel formation by the activated binding component Ib and channel block by the enzyme component Ia J Biol Chem. 277:2002;6143-6152.
47. Blöcker D., Behlke J., Aktories K., Barth H. Cellular uptake of the binary Clostridium perfringens iota-toxin. Infect Immun. 69:2001;2980-2987.
48. Gibert M., Petit L., Raffestin S., Okabe A., Popoff M. Clostridium perfringens iota-toxin requires activation of both binding and enzymatic components for cytopathic activity. Infect Immun. 68:2000;3848-3853.
49. Nagahama M., Nagayasu K., Kobayashi K., Sakurai J. Binding component of Clostridium perfringens iota-toxin induces endocytosis in Vero cells. Infect Immun. 70:2002;1909-1914.
50. Eckhardt M., Barth H., Blöcker D., Aktories K. Binding of Clostridium botulinum C2 toxin to asparagine-linked complex and hybrid carbohydrates. J Biol Chem. 275:2000;2328-2334.
51. Fritz G., Schroeder P., Aktories K. Isolation and characterization of a Clostridium botulinum C2 toxin-resistant cell line. evidence for possible involvement of the cellular C2II receptor in growth regulation Infect Immun. 63:1995;2334-2340.
52. Barth H., Blöcker D., Aktories K. The uptake machinery of clostridial actin ADP-ribosylating toxins - a cell delivery system for fusion proteins and polypeptide drugs. Naunyn-Schmiedeberg's Arch Pharmacol. 366:2002;501-512.
53. Roe S.M., Prodromou C., O'Brien R., Ladbury J.E., Piper P.W., Pearl L.H. Structural basis for inhibition of the Hsp90 molecular chaperone by the antitumor antibiotics radicicol and geldanamycin. J Med Chem. 42:1999;260-266.
54. Young J.C., Moarefi I., Hartl F.U. Hsp90. a specialized but essential protein-folding tool J Cell Biol. 154:2001;267-273.
55. Ratts R., Zeng H., Berg E.A., Blue C., McComb M.E., Costello C.E., Vanderspek J.C., Murphy J.R. The cytosolic entry of diphtheria toxin catalytic domain requires a host cell cytosolic translocation factor complex. J Cell Biol. 160:2003;1139-1150.
56. Haug G., Leemhuis J., Tiemann D., Meyer D.K., Aktories K., Barth H. The host cell chaperone Hsp90 is essential for translocation of the binary Clostridium botulinum C2 toxin into the cytosol. J Biol Chem. 278:2003;32266-32274.